Which drug is marketed under the name Tivicay?

The drug marketed under the name Tivicay is Dolutegravir. This medication is an integrase strand transfer inhibitor (INSTI) used primarily in the treatment of HIV. It works by preventing the integration of viral DNA into the host's genetic material, which is a crucial step in the HIV replication process.

Dolutegravir is favored for its effectiveness, high barrier to resistance, and once-daily dosing without food restrictions. This has made it a key component of many antiretroviral therapy regimens. Understanding the role of Dolutegravir in HIV treatment can assist healthcare professionals in making informed decisions when prescribing therapies for their patients.

The other drugs listed serve different functions or may be marketed under different names, thus distinguishing Dolutegravir as the correct answer in this context.